Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5159]

SEMS trial: result of a prospective, multi-institutional phase II clinical...

Dr Sia Daneshmand - University of Southern California, Los Angeles, USA

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )

Sequencing endocrine treatment in metastatic luminal breast cancer and...

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

Latest developments in the treatment of mRCC

Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald

Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )

Long term response to apalutamide and other updates impacting patients with...

Prof Axel Merseburger and Prof Matthew Smith

Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )

Current treatment standards for primary ovarian cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA

Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA

Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )

Diagnosis, testing and biomarkers in the individualisation of patient care with...

Prof Andrea Necchi and Prof Eva Compérat

Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive...

Dr Ryotaro Nakamura - City of Hope, California, USA

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS ( Dr Ryotaro Nakamura - City of Hope, California, USA )

ITACA NSCLC study: Final results

Prof Silvia Novello - University of Turin, Turin, Italy

ITACA NSCLC study: Final results ( Prof Silvia Novello - University of Turin, Turin, Italy )

Renal liposarcoma: Case report and review of systemic treatment

Dr Abel Centurion - Peruvian National Cancer Institute, Surquillo, Peru

Renal liposarcoma: Case report and review of systemic treatment ( Dr Abel Centurion - Peruvian National Cancer Institute, Surquillo, Peru )

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with...

Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC ( Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia )

TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair...

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France

TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )

More from ecancer